UBS Group’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-145,053
Closed -$174K 10284
2023
Q2
$174K Buy
145,053
+139,505
+2,515% +$171K ﹤0.01% 5582
2023
Q1
$8.43K Sell
5,548
-2,500
-31% -$9.4K ﹤0.01% 7723
2022
Q4
$30.3K Buy
8,048
+2,823
+54% +$14.9K ﹤0.01% 7232
2022
Q3
$26K Hold
5,225
﹤0.01% 7077
2022
Q2
$24K Sell
5,225
-4,044
-44% -$24.7K ﹤0.01% 6672
2022
Q1
$70K Sell
9,269
-13,274
-59% -$108K ﹤0.01% 6179
2021
Q4
$200K Buy
22,543
+17,566
+353% +$180K ﹤0.01% 5688
2021
Q3
$50K Buy
4,977
+3,850
+342% +$43.5K ﹤0.01% 6336
2021
Q2
$19K Hold
1,127
﹤0.01% 7416
2021
Q1
$20K Sell
1,127
-707
-39% -$14.7K ﹤0.01% 7405
2020
Q4
$20K Buy
+1,834
New +$19.1K ﹤0.01% 6963

Other funds holding PTRA

UBS Group's PTRA Position: Q3 2023 in Review

UBS Group sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 145,053 shares — an estimated $174K sold.

UBS Group first reported a position in PTRA in Q4 2020 and held it in 11 quarters. The position peaked at $200K in Q4 2021. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • UBS Group reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 145,053 Proterra Inc. Common Stock shares in Q3 2023, an estimated $174K.
  • UBS Group first reported a position in Proterra Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • UBS Group's Proterra Inc. Common Stock position peaked at $200K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.